High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer

Strahlentherapie und Onkologie

Volumn 186, Issue 1, 2010, Pages 30-35

  Wolff, Hendrik Andreas ^a   Gaedcke, Jochen ^a   Jung, Klaus ^a   Hermann, Robert Michael ^a,b   Rothe, Hilka ^a   Schirmer, Markus ^a   Liersch, Torsten ^a   Herrmann, Markus Karl Alfred ^a   Hennies, Steffen ^a   Rave Fränk, Margret ^a   Hess, Clemens Friedrich ^a   Christiansen, Hans ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Ärztehaus Am Diako ^*  (Germany)

Author keywords

Preoperative radiochemotherapy; Rectal cancer; Side effects; Tumor regression

Indexed keywords

FLUOROURACIL; OXALIPLATIN; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; PLATINUM COMPLEX;

ACUTE ORGAN TOXICITY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COMMON TOXICITY CRITERIA; CONTINUOUS INFUSION; CYSTITIS; DRUG DOSE REDUCTION; ENTERITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PREOPERATIVE TREATMENT; PROCTITIS; RADIATION DOSE FRACTIONATION; RECTUM CANCER; SCORING SYSTEM; TOXICITY; TUMOR CELL; TUMOR REGRESSION; ADJUVANT THERAPY; CANCER STAGING; COMPARATIVE STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RADIATION DOSE; RADIATION INJURY; RECTUM TUMOR; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYSTITIS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENTERITIS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PROCTITIS; PROGNOSIS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; STATISTICS AS TOPIC;

EID: 75649103969     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-009-2037-1     Document Type: Article

References (31)

1. D. Beddy J.M. Hyland D.C. Winter 2008 A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy Ann Surg Oncol 15 3471 7 10.1245/s10434-008-0149-y 1:STN:280:DC%2BD1M%2FhvVWktA%3D%3D 18846402
2. J.A. Bonner P. Harari J. Giralt 2005 The relationship of cetuximab-induced rash and survival in patients with head and neck cancer treated with radiotherapy and cetuximab Int J Radiat Oncol Biol Phys 63 S73
3. K. Borgmann U. Hoeller S. Nowack 2008 Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy Int J Radiat Oncol Biol Phys 71 256 64 18406889
4. J. Chavaudra 1998 Last ICRU recommendations for the prescription, recording and reporting of external bean therapy Cancer Radiother 2 607 14 1:STN:280:DyaK1M%2FosFaqug%3D%3D 9868407
5. H. Christiansen R.M. Hermann A. Hille 2004 Concomitant radiochemotherapy in primary inoperable advanced head and neck cancer with 5-fluorouracil and mitomycin-C Head Neck 26 845 53 10.1002/hed.20030 15390205 (Pubitemid 39299303)
6. C.H. Crane N.A. Janjan K. Mason 2002 Preoperative chemoradiation for locally advanced rectal cancer: emerging treatment strategies Oncology (Williston Park) 16 39 44
7. J. Cuzick I. Sestak D. Cella 2008 Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial Lancet Oncol 9 1143 8 10.1016/S1470-2045(08)70259-6 1:CAS:528: DC%2BD1cXhsVWrsL7J 18976959
8. O. Dahl A. Horn O. Mella 1994 Do acute side-effects during radiotherapy predict tumour response in rectal carcinoma? Acta Oncol 33 409 13 10.3109/02841869409098437 1:STN:280:DyaK2c3ovFSmsg%3D%3D 8018374
9. T. Daly M.G. Poulsen J.W. Denham 2003 The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck Radiother Oncol 68 113 22 10.1016/S0167-8140(03)00198-1 12972305 (Pubitemid 38367543)
10. 2008;184:169-74.
11. Deutsche Gesellschaft der epidemiologischen Krebsregister. Broschure.,Krebs in Deutschland", 5. Aufl. Berlin: Robert-Koch-Institut, 2006.
12. A. Dietz V. Rudat C. Conradt 2000 Prognostic value of hemoglobin level for primary radiochemotherapy of head-neck carcinomas HNO 48 655 64 10.1007/s001060050635 1:STN:280:DC%2BD3crgs1GrsA%3D%3D 11056853 (Pubitemid 30735814)
13. H.T. Eich M. Loschcke M. Scheer 2008 Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients Strahlenther Onkol 184 23 9 10.1007/s00066-008-1725-6 18188519
14. D.A. Fein W.R. Lee A.L. Hanlon 1995 Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx J Clin Oncol 13 2077 83 1:CAS:528:DyaK2MXntlKku7g%3D 7636551
15. M. Gavioli A. Bagni I. Piccagli 2000 Usefulness of endorectal ultrasound after preoperative radiotherapy in rectal cancer: comparison between sonographic and histopathologic changes Dis Colon Rectum 43 1075 83 10.1007/BF02236553 1:STN:280:DC%2BD3cvitVSgsQ%3D%3D 10950005
16. R. Glynne-Jones M. Wallace J.I. Livingstone 2008 Complete clinical response after preoperative chemoradiation in rectal cancer: is a "wait and see" policy justified? Dis Colon Rectum 51 10 9 10.1007/s10350-007-9080-8 1:STN:280:DC%2BD1c%2FjsF2htA%3D%3D 18043968
17. D.G. Grant A. Hussain D. Hurman 1999 Pre-treatment anaemia alters outcome in early squamous cell carcinoma of the larynx treated by radical radiotherapy J Laryngol Otol 113 829 33 1:STN:280:DC%2BD3c7ivVSksA%3D%3D 10664687
18. A. Haydaroglu V. Yurut A. Arican 2002 The impact of the haemoglobin level on the response to radiotherapy J BUON 7 31 4 1:STN:280:DC%2BD2szmt1CrtA%3D%3D 17577257
19. T. Herrmann S. Petersen G. Hellmich 1999 Delayed toxicity of brief preoperative irradiation and risk-adjusted postoperative radiotherapy of operative rectal carcinoma. Results of a randomized prospective study Strahlenther Onkol 175 430 6 10.1007/s000660050032 1:STN:280: DyaK1MvkvVChsw%3D%3D 10518976 (Pubitemid 29438812)
20. I.D. Nagtegaal M.J. Gosens C.A. Marijnen 2007 Combinations of tumor and treatment parameters are more discriminative for prognosis than the present TNM system in rectal cancer J Clin Oncol 25 1647 50 10.1200/JCO.2005.05.4825 17470856 (Pubitemid 46797942)
21. O. Pradier K. Lederer A. Hille 2005 Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter J Cancer Res Clin Oncol 131 261 9 10.1007/s00432-004-0633-0 1:CAS:528:DC%2BD2MXhtV2ktbw%3D 15616830 (Pubitemid 40238943)
22. D. Rades M. Stoehr T. Meyners 2008 Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer Strahlenther Onkol 184 198 205 10.1007/s00066-008-1825-3 18398584
23. C. Rödel P. Martus T. Papadoupolos 2005 Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer J Clin Oncol 23 8688 96 10.1200/JCO.2005.02.1329 16246976 (Pubitemid 46211512)
24. C. Rödel R. Sauer 2007 Integration of novel agents into combined-modality treatment for rectal cancer patients Strahlenther Onkol 183 227 35 10.1007/s00066-007-9000-9 17497093 (Pubitemid 46725993)
25. M.W. Saif S. Hashmi D. Zelterman 2008 Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review Int J Colorectal Dis 23 139 45 10.1007/s00384-007-0382-z 1:STN:280: DC%2BD2sjjsl2gtQ%3D%3D 17909820 (Pubitemid 350302509)
26. R. Sauer H. Becker W. Hohenberger 2004 Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731 40 10.1056/NEJMoa040694 1:CAS:528:DC%2BD2cXovFSksbo%3D 15496622 (Pubitemid 39383208)
27. Sobin LH, Wittekind C. TNM classification of malignant tumours, 6th edn. New York-Toronto: Wiley-Liss, 2002.
28. H. Strasser G.G. Grabenbauer C.N. Sprung 2007 DNA double-strand break induction and repair in irradiated lymphoblastoid, fibroblast cell lines and white blood cells from ATM, NBS and radiosensitive patients Strahlenther Onkol 183 447 53 10.1007/s00066-007-1683-4 17680225 (Pubitemid 47240931)
29. A. Trotti R. Byhardt J. Stetz 2000 Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy Int J Radiat Oncol Biol Phys 47 13 47 1:STN:280: DC%2BD3c3itlCjsg%3D%3D 10758303
30. R.F. Vliegen R.G. Beets-Tan B. Vanhauten 2008 Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer? Strahlenther Onkol 184 457 64 10.1007/s00066-008-1858-7 19016024
31. H. Vorwerk T. Liersch H. Rothe 2010 Gold markers for tumor localization and target volume delineation in radiotherapy for rectal cancer Strahlenther Onkol 185 127 33 10.1007/s00066-009-1928-5